Drug Profile
Progesterone vaginal - Ferring Pharmaceuticals
Alternative Names: Endometrin; FE 999 913; FE 99913; Lutinus; Progesterone vaginal tablet - FerringLatest Information Update: 26 Feb 2023
Price :
$50
*
At a glance
- Originator Ferring Pharmaceuticals
- Class Hormonal contraceptives; Hormonal replacements; Infertility therapies; Pregnenediones; Small molecules
- Mechanism of Action Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Female infertility
Most Recent Events
- 01 Dec 2022 Phase-II clinical trials in Female infertility in Canada (Vaginal) (NCT05555121)
- 29 Aug 2013 Ferring completes a phase III trial in Female infertility in Japan (NCT01710514)
- 31 Oct 2012 Phase-III clinical trials in Female infertility in Japan (Vaginal)